Bile acid-induced mallory body formation in drug-primed mouse liver

American Journal of Pathology

Volumn 161, Issue 6, 2002, Pages 2019-2026

  Fickert, Peter ^a   Trauner, Michael ^a   Fuchsbichler, Andrea ^a   Stumptner, Conny ^a   Zatloukal, Kurt ^a   Denkt, Helmut ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; ANTIBODY; BILE ACID; CHOLIC ACID; CYTOKERATIN 18; CYTOKERATIN 8; MESSENGER RNA; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOSKELETON; DRUG INTOXICATION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; MALLORY BODY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0036900927     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64480-X     Document Type: Article

References (51)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24
2. Denk H, Stumptner C, Zatloukal K: Mallory bodies revisited. J Hepatol 2000, 32:689-702
3. Mallory FB: Cirrhosis of the liver: Five different lesions from which it may arise. Bull Johns Hopkins Hosp 1911, 22:69-75
4. Stumptner C, Fuchsbichler A, Lehner M, Zatloukal K, Denk H: Sequence of events in the assembly of Mallory body components in mouse liver: Clues to the pathogenesis and significance of Mallory body formation. J Hepatol 2001, 34:665-675
5. Zatloukal K, Bock G, Rainer I, Denk H, Weber K: High molecular weight components are main constituents of Mallory bodies isolated with fluorescence activated cell sorter. Lab Invest 1991, 64:200-206
6. Zatloukal K, Denk H, Spurej G, Lackinger E, Preisegger KH, Franke WW: High molecular weight component of Mallory bodies detected by monocional antibody. Lab Invest 1990, 62:427-434
7. Denk H, Franke WW, Dragosics B, Zeiler I: Pathology of cytoskeleton of liver cells: Demonstration of Mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Hepatology 1981, 1:9-20
8. Stumptner C, Omary MB, Fickert P, Denk H, Zatloukal K: Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in Mallory bodies. Am J Pathol 2000, 156:77-90
9. Hazan R, Denk H, Franke WW, Lackinger E, Schiller DL: Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest 1986, 54:543-553
10. Zatloukal K, Stumptner C, Lehner M, Denk H, Baribault H, Eshkind LG, Franke WW: Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am J Pathol 2000, 156:1263-1274
11. Gerber MA, Orr W, Denk H, Schaffner F, Popper H: Hepatocellular hyalin in cholestasis and cirrhosis: Its diagnostic significance. Gastroenterology 1973, 64:89-98
12. Denk H, Franke WW, Kerjaschki D, Eckersdorfer R: Mallory bodies in experimental animals and man. Int Rev Exp Pathol 1979, 20:1061-1077
13. Denk H, Gschnait F. Wolff K: Hepatocellular hyalin (Mallory bodies) in long term griseofulvin-treated mice A new experimental model for the study of hyalin formation. Lab Invest 1975, 32:773-776
14. Denk H, Eckersdorfer R, Gschnait F, Konrad K, Wolff K: Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. Light microscopic observations. Lab Invest 1976, 35:377-382
15. Yokoo H, Harwood TR, Racker D, Arak S: Experimental production of Mallory bodies in mice by diet containing 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Gastroenterology 1982, 83:109-113
16. Yokoo H, Craig RM, Harwood TR, Cochrane C: Griseofulvin-induced cholestasis in Swiss albino mice. Gastroenterology 1979, 77:1082-1087
17. , Meermann L, Koopen NR, Bloks V, Van Goor H, Havinga R, Walthers BG, Kramer W, Stegelin S, Muller M, Kuipers F, Jansen PL: Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology 1999, 117:696-705
18. Yuan QX, Marceau N, French BA, Fu P, French SW: Mallory body induction in drug-primed mouse liver, Hepatology 1996, 24:603-612
19. Yuan QX, Nagao Y, Gaal K, Hu B, French SW: Mechanism of Mallory body formation induced by okadaic acid in drug-primed mice. Exp Mol Pathol 1998, 65:87-103
20. Yuan Q, French BA, French SW: Tautomycin induces extensive Mallory body formation in drug-primed mouse livers. Hepatology 1998, 28:256A
21. Zatloukal K, Spurej G, Lackinger E, Rainer I, Denk H: Fate of Mallory body containing hepatocytes: Disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin treated mouse. Hepatology 1990, 11:652-661
22. Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H: Cytokeratins as targets for bile acid induced cytotoxicity. Am J Pathol 2002, 160:491-499
23. Trauner M, Arrese M, Soroka CJ, Anathanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL: The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997, 113:255-264
24. Fickert P, Zollner G, Fuchsbichler A, Pojer C, Zenz R, Stumptner C, Pojer C, Zenz R, Lammert F, Stieger B, Meier PJ, Zatloukal K, Denk H, Trauner M: Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001, 120:170-183
25. Hutter H, Zatloukal K, Winter G, Stumptner C, Denk H: Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Lab Invest 1993, 69:576-582
26. Liao J, Ku N, Omary MB: Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at ser73 in tissues and cultured cells. J Biol Chem 1995, 272:17565-17573
27. Miyoshi H, Rust C, Guicciardi ME, Gores GJ: NF-kappa B is activated in cholestasis and functions to reduce liver injury. Am J Pathol 2001, 158:967-975
28. Trauner M, Graziadei IW: Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver disease. Aliment Pharm Ther 1999, 13:979-996
29. Hofmann AF: The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999, 159:2647-2658
30. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H: p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002, 160:255-263
31. Ohta M, Marceau N, Perry G, Manetto V, Gambetti P, Autilio-Gambetti L, Metuzals J, Kawahara H, Cadrin M, French SW: Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 1988, 59:848-856
32. Lowe J, Blanchard K, Morrell K, Lennox L, Reynolds M, Billett M, Landon M, Mayer RJ: Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988, 155:9-15
33. Ku NO, Omary MB: Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J Cell Biol 2000, 149:547-552
34. Carrell RW, Lomas DA: Conformational diseases. Lancet 1997, 350: 134-138
35. Haruda M, Skisaka S, Terada K, Kimura K, Krawaguchi T, Koga H, Kim H, Taniguchi E, Harada S, Sugamura T, Furuta K, Sugiyama T, Salon M: A mutation of Wilsons' disease protein, ATP 7B, is degraded in the proteasomes and forms protein aggregates. Gastroenterology 2001, 120:967-974
36. Caulin C, Ware CF, Magin TM, Oshima RG: Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J Cell Biol 2000, 149:17-22
37. MacFarlan M, Merrison W, Dinskale D, Cohen MG: Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 2000, 148:1239-1254
38. Ku NO, Michie SA, Soetikno RM, Resurreccion EZ, Broome RL, Oshima RG, Omary MB: Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest 1996, 98:1034-1046
39. Gilbert S, Loranger A, Daigle N, Marceau N: Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J Cell Biol 2001, 154:763-773
40. Ku N, Michie SA, Soetikno RM, Resurreccion EZ, Broome RL, Omary MB: Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J Cell Biol 1998, 143:2023-2032
41. Ku NO, Wright TL, Terrault NA, Grish R, Omary MB: Mutation of human keratin 18 is associated with cryptogenic cirrhosis. J Clin Invest 1997, 99:19-23
42. Ku NO, Grish R, Wright TL, Omary MB: Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med 2001, 344:1580-1587
43. Cienchanover A, Schwartz AL: Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 2002, 35:3-6
44. Hershko A, Ciechanover A: The ubiquitin system for protein degradation. Annu Rev Biochem 1992, 67:761-807
45. Rivett AJ: Proteasomes: Multicatalytic proteinase complexes. Biochem J 1993, 291:1-10
46. Goldberg AL, Rock KL: Proteolysis, proteasomes and antigen presentation. Nature 1992, 357:375-379
47. Hochstrasser M: Ubiquitin and intracellular protein degradation. Curr Opin Cell Biol 1992, 4:1024-1031
48. Oiao D, Goritonde SV, Qi W, Martinez JD: Deoxycholic acid suppresses p53 by stimulation proteasome-mediated p53 degradation. Carcinogenesis 2001, 22:957-964
49. Denk H, Stumptner C, Fuchsbichler A, Zatloukal K: Alcoholic and nonalcoholic steatohepatitis. Histopathologic and pathogenetic considerations. Pathologe 2001, 22:388-398
50. Sokol RJ, Straka MS, Dahl R, Devereaux MW, Yerushalmi B, Gumricht E, Elkins N, Everson G: Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr Res 2001, 49:519-531
51. Sokol RJ, McKim AM, Goff MC, Ruyle SZ, Devereaux MW, Han D, Packer L, Everson G: Vitamin E reduces oxidant injury to mitochonria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 1998, 114:164-174